Characterization of Structure and Function of ZS-9, α K+ Selective Ion Trap

被引:146
作者
Stavros, Fiona [1 ]
Yang, Alex [2 ]
Leon, Alejandro [1 ]
Nuttall, Mark [1 ]
Rasmussen, Henrik S. [1 ]
机构
[1] ZS Pharma Inc, Coppell, TX 75019 USA
[2] Xelay Acumen Inc, Belmont, CA USA
关键词
HEART-FAILURE; HYPERKALEMIA; POTASSIUM; SPIRONOLACTONE; ZIRCONIUM; MORTALITY; RESIN;
D O I
10.1371/journal.pone.0114686
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Hyperkalemia, a condition in which serum potassium ions (K+) exceed 5.0 mmol/L, is a common electrolyte disorder associated with substantial morbidity. Current methods of managing hyperkalemia, including organic polymer resins such as sodium polystyrene sulfonate (SPS), are poorly tolerated and/or not effective. Sodium zirconium cyclosilicate (ZS-9) is under clinical development as an orally administered, non-absorbed, novel, inorganic microporous zirconium silicate compound that selectively removes excess K+ in vivo. The development, structure and ion exchange properties of ZS-9 and its hypothesized mechanism of action are described. Based on calculation of the interatomic distances between the atoms forming the ZS-9 micropores, the size of the pore opening was determined to be similar to 3 angstrom (similar to diameter of unhydrated K+). Unlike nonspecific organic polymer resins like SPS, the ZS-9 K+ exchange capacity (KEC) was unaffected by the presence of calcium (Ca2+) or magnesium ions (Mg2+) and showed. 25-fold selectivity for K+ over either Ca2+ or Mg2+. Conversely, the selectivity of SPS for K+ was only 0.2-0.3 times its selectivity for Ca2+ or Mg2+ in mixed ionic media. It is hypothesized that the high K+ specificity of ZS-9 is attributable to the chemical composition and diameter of the micropores, which possibly act in an analogous manner to the selectivity filter utilized by physiologic K+ channels. This hypothesized mechanism of action is supported by the multi-ion exchange studies. The effect of pH on the KEC of ZS-9 was tested in different media buffered to mimic different portions of the human gastrointestinal tract. Rapid K+ uptake was observed within 5 minutes - mainly in the simulated small intestinal and large intestinal fluids, an effect that was sustained for up to 1 hour. If approved, ZS-9 will represent a novel, first-in-class therapy for hyperkalemia with improved capacity, selectivity, and speed for entrapping K+ when compared to currently available options.
引用
收藏
页数:12
相关论文
共 34 条
[11]   Survival and heart failure therapy in chronic dialysis patients with heart failure and reduced left ventricular ejection fraction: an observational retrospective study [J].
Derthoo, David ;
Belmans, Ann ;
Claes, Kathleen ;
Bammens, Bert ;
Ciarka, Agniezka ;
Droogne, Walter ;
Vanhaecke, Johan ;
Van Cleemput, Johan ;
Janssens, Stefan .
ACTA CARDIOLOGICA, 2013, 68 (01) :51-57
[12]   The structure of the potassium channel:: Molecular basis of K+ conduction and selectivity [J].
Doyle, DA ;
Cabral, JM ;
Pfuetzner, RA ;
Kuo, AL ;
Gulbis, JM ;
Cohen, SL ;
Chait, BT ;
MacKinnon, R .
SCIENCE, 1998, 280 (5360) :69-77
[13]   Management of patients with acute hyperkalemia [J].
Elliott, Meghan J. ;
Ronksley, Paul E. ;
Clase, Catherine M. ;
Ahmed, Sofia B. ;
Hemmelgarn, Brenda R. .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2010, 182 (15) :1631-1635
[14]   EFFECT OF 3 LAXATIVES AND A CATION-EXCHANGE RESIN ON FECAL SODIUM AND POTASSIUM EXCRETION [J].
EMMETT, M ;
HOOTKINS, RE ;
FINE, KD ;
ANA, CAS ;
PORTER, JL ;
FORDTRAN, JS .
GASTROENTEROLOGY, 1995, 108 (03) :752-760
[15]   Serum potassium and cardiovascular mortality [J].
Fang, J ;
Madhavan, S ;
Cohen, H ;
Alderman, MH .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2000, 15 (12) :885-890
[16]   Disorders of potassium homeostasis Hypokalemia and hyperkalemia [J].
Gennari, FJ .
CRITICAL CARE CLINICS, 2002, 18 (02) :273-+
[17]   Therapeutic approach to hyperkalemia [J].
Kim, HJ ;
Han, SW .
NEPHRON, 2002, 92 :33-40
[18]   Effect of Sodium Zirconium Cyclosilicate on Potassium Lowering for 28 Days Among Outpatients With Hyperkalemia The HARMONIZE Randomized Clinical Trial [J].
Kosiborod, Mikhail ;
Rasmussen, Henrik S. ;
Lavin, Philip ;
Qunibi, Wajeh Y. ;
Spinowitz, Bruce ;
Packham, David ;
Roger, Simon D. ;
Yang, Alex ;
Lerma, Edgar ;
Singh, Bhupinder .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (21) :2223-2233
[19]   Zirconium: Biomedical and Nephrological Applications [J].
Lee, David B. N. ;
Roberts, Martin ;
Bluchel, Christian G. ;
Odell, Ross A. .
ASAIO JOURNAL, 2010, 56 (06) :550-556
[20]   Pathogenesis, diagnosis and management of hyperkalemia [J].
Lehnhardt, Anja ;
Kemper, Markus J. .
PEDIATRIC NEPHROLOGY, 2011, 26 (03) :377-384